Omega-3 fatty acids, specialized pro-resolving mediators, and depression: A mechanistic meta-analysis of precursors and clinical implications.
Ayesha Zafar Iqbal, Aimal Khan, Ikbal Andrian Malau et al.
✦ AI-curated · Sources linked
In 30 seconds
This random-effects meta-analysis examined whether omega-3 polyunsaturated fatty acid supplementation increases circulating precursors of specialized pro-resolving mediators in humans. It included 11 randomised controlled trials with 810 participants. Supplementation increased 18-HEPE (SMD = 1.05, 95% CI 0.54-1.55) and 17-HDHA (SMD = 0.69, 95% CI 0.19-1.18). Subgroup analyses suggested larger increases in populations with inflammatory, metabolic, or oxidative burden, while changes were negligible in healthy infants. The findings support an effect on precursor availability, but do not establish increased downstream mediator production or antidepressant benefit.
Key findings
- Across 11 RCTs involving 810 participants, supplementation increased 18-HEPE (SMD = 1.05, 95% CI 0.54-1.55, P = 0.0001).
- Supplementation also increased 17-HDHA (SMD = 0.69, 95% CI 0.19-1.18, P = 0.006).
- Subgroup increases were amplified in populations with inflammatory, metabolic, or oxidative burden, but negligible in healthy infants.
Why it matters
The results provide human trial evidence that omega-3 supplementation can raise circulating precursors in a proposed inflammation-resolving pathway. This helps clarify a possible biological mechanism relevant to depression research, but precursor concentrations are not equivalent to downstream mediator activity or clinical improvement. The distinction is important when interpreting mechanistic evidence alongside claims of antidepressant efficacy.
What to keep in mind
The meta-analysis measured circulating precursor concentrations, not downstream specialized pro-resolving mediator production or clinical antidepressant effects; the authors state that these links remain uncertain.